Mural Oncology plc
MURA
$2.09
-$0.01-0.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.37% | -9.47% | -42.92% | 4.18% | 19.94% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.52% | 1.03% | -38.72% | -26.37% | -27.47% |
| Operating Income | 8.52% | -1.03% | 38.72% | 26.37% | 27.47% |
| Income Before Tax | -52.01% | -7.18% | 40.46% | 31.43% | 33.21% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -52.01% | -7.18% | 42.43% | 38.07% | 37.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -52.01% | -7.18% | 42.43% | 38.07% | 37.08% |
| EBIT | 8.52% | -1.03% | 38.72% | 26.37% | 27.47% |
| EBITDA | 9.47% | -1.04% | 39.57% | 27.09% | 28.39% |
| EPS Basic | -48.96% | -4.84% | 43.71% | 39.30% | 37.95% |
| Normalized Basic EPS | 5.32% | -4.84% | 41.78% | 32.79% | 34.14% |
| EPS Diluted | -48.96% | -4.84% | 43.71% | 39.30% | 37.95% |
| Normalized Diluted EPS | 5.32% | -4.84% | 41.78% | 32.79% | 34.14% |
| Average Basic Shares Outstanding | 2.05% | 2.23% | 2.27% | 2.03% | 1.41% |
| Average Diluted Shares Outstanding | 2.05% | 2.23% | 2.27% | 2.03% | 1.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |